{"id":"https://openalex.org/W2625712844","doi":"https://doi.org/10.2174/978160805206610603010399","title":"Small Molecule FLT3 Tyrosine Kinase Inhibitors","display_name":"Small Molecule FLT3 Tyrosine Kinase Inhibitors","publication_year":2010,"publication_date":"2010-12-18","ids":{"openalex":"https://openalex.org/W2625712844","doi":"https://doi.org/10.2174/978160805206610603010399","mag":"2625712844"},"language":"en","primary_location":{"id":"doi:10.2174/978160805206610603010399","doi":"https://doi.org/10.2174/978160805206610603010399","is_oa":false,"landing_page_url":"https://doi.org/10.2174/978160805206610603010399","pdf_url":null,"source":{"id":"https://openalex.org/S4306462908","display_name":"BENTHAM SCIENCE PUBLISHERS eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicinal Chemistry - (Volume 3)","raw_type":"book-chapter"},"volume":null,"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089694123","display_name":"Mark J. Levis","orcid":"https://orcid.org/0000-0003-0473-6982","observed_orcids":["https://orcid.org/0000-0003-0473-6982","https://orcid.org/0000-0003-4219-6315"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Levis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Donald Small","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Donald Small","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.45048966,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"399","last_page":"416"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/flt3-inhibitors","display_name":"FLT3 inhibitors","score":0.9470000267028809},{"id":"https://openalex.org/keywords/flt3-mutation","display_name":"FLT3 mutation","score":0.7609999775886536},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.996999979019165},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.9210000038146973},{"id":"https://openalex.org/keywords/kinase-assay","display_name":"kinase activity assay","score":0.45100000500679016},{"id":"https://openalex.org/keywords/clinical-drug-development","display_name":"clinical development","score":0.46700000762939453},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.5830000042915344}],"concepts":[{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5894964337348938},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.4747610092163086},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.4728165864944458},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4492378532886505},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.40931281447410583},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.3409455418586731},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2794688940048218},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.26661622524261475},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.16811341047286987}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2174/978160805206610603010399","doi":"https://doi.org/10.2174/978160805206610603010399","is_oa":false,"landing_page_url":"https://doi.org/10.2174/978160805206610603010399","pdf_url":null,"source":{"id":"https://openalex.org/S4306462908","display_name":"BENTHAM SCIENCE PUBLISHERS eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicinal Chemistry - (Volume 3)","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8048999905586243,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.6600000262260437,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2168084500","https://openalex.org/W2137971342","https://openalex.org/W185852413","https://openalex.org/W3042883236","https://openalex.org/W2063512315","https://openalex.org/W1969130273","https://openalex.org/W2109890598","https://openalex.org/W4388772760","https://openalex.org/W2620680746","https://openalex.org/W2080109272"],"abstract_inverted_index":{"Activating":[0],"mutations":[1],"of":[2,29,36],"FLT3":[3,41],"(FMS-Like":[4],"Tyrosine":[5],"kinase-3)":[6],"are":[7],"the":[8,27,34,63],"most":[9],"common":[10],"molecular":[11],"abnormality":[12],"in":[13],"acute":[14],"myeloid":[15],"leukemia":[16],"(AML).":[17],"Their":[18],"presence":[19],"is":[20],"associated":[21],"with":[22,60],"a":[23],"worse":[24],"prognosis,":[25],"and":[26,52,54],"recognition":[28],"this":[30,46],"has":[31],"led":[32],"to":[33,62,66,72],"development":[35],"several":[37],"new":[38],"small":[39],"molecule":[40],"tyrosine":[42],"kinase":[43],"inhibitors.":[44],"In":[45],"review,":[47],"we":[48],"summarize":[49],"these":[50,56],"developments":[51],"compare":[53],"contrast":[55],"novel":[57],"agents":[58],"both":[59],"regards":[61],"assays":[64],"used":[65],"characterize":[67],"them":[68],"as":[69,71],"well":[70],"their":[73],"clinical":[74],"potential.":[75]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2017-06-23T00:00:00"}